News from CNBC Business
What is your interest today?
Tariffs
Investors
Ceo
Stock
Shares
Earnings
Stocks
Eqs
China
Cet
Nasdaq
Investment
Markets
Wall Street
Tesla
Nvidia
Trade
Inflation
Revenue
Securities
Class Action
Stock Market
Bitcoin
Economy
Company
Us
Federal Reserve
Sales
Apple
Prices
Trade War
Sp 500
Pvr
Ipo
Crypto
Interest Rates
Companies
Amazon
Shareholders
Federal Securities Laws
German Securities Trading Act
Voting Rights
Guidance
Warren Buffett
Trading
Gop
Elon Musk
Securities Laws
Berkshire Hathaway
Investor
United Airlines
Dow
Saudi
Dealmaking
Peapack Gladstone Financial Corporation
Bear Markets
Bessor Minerals
Arkansas Law
Us Government
Big Banks
CNBC Business • May 21, 2025
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Cigna’s Evernorth division reached an agreement that aims to reduce out-of-pocket expenses for employers and employees on certain weight management medications from Eli Lilly and N...
Read Full Article →
CNBC Business • May 19, 2025
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Novo Nordisk’s leadership change aims to strengthen its position in the weight loss market, improve competitive standing against Eli Lilly, and address upcoming industry challenges...
Read Full Article →
CNBC Business • May 01, 2025
Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer...
Eli Lilly experienced a significant increase in sales attributed to strong demand for its weight loss and diabetes medications, yet adjusted its profit forecast following a recent...
Read Full Article →